Location: NEW YORK, NY
CIK: 0001633313 · Show all filings
Period: Q4 2021 (← Previous) (Next →)
Filing Date: Feb 14, 2022
Total Value ($000): $5,875,773 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | HORIZON THERAPEUTICS PLC | 9,295,000 | $1,001,629 | 17.0% | $48.54 | — | Common | G46188101 |
| — | MIRATI THERAPEUTICS INC | 5,075,000 | $744,452 | 12.7% | $51.83 | — | Common | 60468T105 |
| UTHR | UNITED THERAPEUTICS CORP | 3,035,000 | $655,803 | 11.2% | $133.73 | +46.8% | Common | 91307C102 |
| APLS | APELLIS PHARMACEUTICALS INC | 8,555,555 | $404,507 | 6.9% | $48.16 | -18.2% | Common | 03753U106 |
| ARGX | ARGENX SE | 965,000 | $337,933 | 5.8% | $83.19 | — | Sponsored ADR | 04016X101 |
| SRPT | SAREPTA THERAPEUTICS INC | 3,125,000 | $281,406 | 4.8% | $99.17 | -13.8% | Common | 803607100 |
| ASND | ASCENDIS PHARMA | 2,000,000 | $269,060 | 4.6% | $132.69 | — | Sponsored ADR | 04351P101 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 2,800,000 | $247,380 | 4.2% | $83.48 | -1.2% | Common | 09061G101 |
| FOLD | AMICUS THERAPEUTICS INC | 18,500,000 | $213,675 | 3.6% | $11.30 | -1.3% | Common | 03152W109 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 1,075,000 | $182,299 | 3.1% | $154.71 | +20.1% | Common | 02043Q107 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 8,675,000 | $165,606 | 2.8% | $16.48 | +33.6% | Common | 462260100 |
| XENE | XENON PHARMACEUTICALS INC | 4,985,000 | $155,731 | 2.7% | $16.29 | +83.4% | Common | 98420N105 |
| — | IVERIC BIO INC | 7,250,000 | $121,220 | 2.1% | $6.39 | — | Common | 46583P102 |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 1,425,000 | $120,755 | 2.1% | $124.06 | -33.8% | Common | 558868105 |
| XBI | SPDR SERIES TRUST - S&P BIOTECH | 1,050,000 | $117,558 | 2.0% | $111.96 | — | ETF | 78464A870 |
| — | ARENA PHARMACEUTICALS INC | 1,235,000 | $114,781 | 2.0% | $72.64 | — | Common | 040047607 |
| GLUE | MONTE ROSA THERAPEUTICS INC | 3,311,434 | $67,619 | 1.2% | $20.37 | +2.8% | Common | 61225M102 |
| KURA | KURA ONCOLOGY INC | 4,000,000 | $56,000 | 1.0% | $25.17 | -35.6% | Common | 50127T109 |
| ACAD | ACADIA PHARMACEUTICALS INC | 2,200,000 | $51,348 | 0.9% | $48.41 | -58.4% | Common | 004225108 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 2,175,000 | $47,611 | 0.8% | $20.70 | -10.7% | Common | 87164F105 |
| WHWK | AADI BIOSCIENCES INC | 1,829,402 | $44,180 | 0.8% | $30.48 | -17.6% | Common | 00032Q104 |
| — | MERSANA THERAPEUTICS INC | 6,800,000 | $42,296 | 0.7% | $23.19 | — | Common | 59045L106 |
| MNKD | MANNKIND CORP | 8,800,000 | $38,456 | 0.7% | $3.55 | +30.3% | Common | 56400P706 |
| — | MARINUS PHARMACEUTICALS INC | 3,235,000 | $38,432 | 0.7% | $12.20 | — | Common | 56854Q200 |
| — | PRAXIS PRECISION MEDICINES INC | 1,780,000 | $35,066 | 0.6% | $41.53 | — | Common | 74006W108 |
| DSGN | DESIGN THERAPEUTICS INC | 1,636,100 | $35,029 | 0.6% | $29.71 | -42.2% | Common | 25056L103 |
| KYMR | KYMERA THERAPEUTICS INC | 550,000 | $34,920 | 0.6% | $58.02 | +0.4% | Common | 501575104 |
| — | CYMABAY THERAPEUTICS INC | 10,300,000 | $34,814 | 0.6% | $6.26 | — | Common | 23257D103 |
| PMVP | PMV PHARMACEUTICALS INC | 1,465,000 | $33,842 | 0.6% | $35.29 | -31.5% | Common | 69353Y103 |
| KRYS | KRYSTAL BIOTECH INC | 475,000 | $33,226 | 0.6% | $58.21 | 0.0% | Common | 501147102 |
| RNAM | AVIDITY BIOSCIENCES INC | 1,230,000 | $29,237 | 0.5% | $25.02 | -4.5% | Common | 05370A108 |
| — | AMARIN CORP PLC | 6,000,000 | $20,220 | 0.3% | $8.22 | — | Sponsored ADR | 023111206 |
| NUVL | NUVALENT INC | 1,102,671 | $18,431 | 0.3% | $29.01 | -23.2% | Common | 670703107 |
| TNGX | TANGO THERAPEUTICS INC | 1,550,000 | $16,957 | 0.3% | $11.99 | +0.3% | Common | 87583X109 |
| — | DICE THERAPEUTICS INC | 562,500 | $14,237 | 0.2% | $32.75 | — | Common | 23345J104 |
| — | AVADEL PHARMACEUTICALS PLC | 1,670,000 | $13,494 | 0.2% | $7.90 | — | Sponsored ADR | 05337M104 |
| — | ADVERUM BIOTECHNOLOGIES INC | 6,950,000 | $12,232 | 0.2% | $11.14 | — | Common | 00773U108 |
| IOBT | IO BIOTECH INC | 2,055,883 | $10,243 | 0.2% | $9.66 | 0.0% | Common | 449778109 |
| GNCAQ | GENOCEA BIOSCIENCES INC | 5,084,184 | $5,898 | 0.1% | $2.62 | -43.2% | Common | 372427401 |
| FENC | FENNEC PHARMACEUTICALS INC | 1,200,000 | $5,280 | 0.1% | $9.85 | -24.5% | Common | 31447P100 |
| SRPT | SAREPTA THERAPEUTICS INC | 300,000 | $2,910 | 0.0% | $99.17 | -13.8% | Call | 803607100 |